The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT04303780




Registration number
NCT04303780
Ethics application status
Date submitted
5/03/2020
Date registered
11/03/2020
Date last updated
28/03/2024

Titles & IDs
Public title
Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200).
Scientific title
A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects With Mutated KRAS p.G12C
Secondary ID [1] 0 0
2023-508214-42-00
Secondary ID [2] 0 0
20190009
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
KRAS p, G12c Mutated /Advanced Metastatic NSCLC 0 0
Condition category
Condition code
Cancer 0 0 0 0
Lung - Non small cell

Intervention/exposure
Study type
Interventional(has expanded access)
Description of intervention(s) / exposure
Treatment: Drugs - AMG 510
Treatment: Drugs - Docetaxel

Experimental: AMG 510 -

Active Comparator: Docetaxel -


Treatment: Drugs: AMG 510
21 day cycles

Treatment: Drugs: Docetaxel
21 day cycles

Intervention code [1] 0 0
Treatment: Drugs
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Progression-free Survival (PFS)
Timepoint [1] 0 0
Baseline up to primary analysis data cut-off date (02 August 2022); max time on study as of primary analysis data cut off was 24.3 months

Eligibility
Key inclusion criteria
- Men or women greater than or equal to 18 years old.

- ECOG = 1

- Pathologically documented, previously treated, locally-advanced and unresectable or
metastatic NSCLC with KRAS p.G12C mutation confirmed through central testing or have
documentation of KRAS p.G12C mutation through Amgen Study 20190294 prior to enrollment
Minimum age
18 Years
Maximum age
100 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- Active brain metastases

- Myocardial infarction within 6 months of study day 1

- Gastrointestinal (GI) tract disease causing the inability to take oral medication

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Phase 3
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Active, not recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,VIC,WA
Recruitment hospital [1] 0 0
Blacktown Hospital - Blacktown
Recruitment hospital [2] 0 0
Chris OBrien Lifehouse - Camperdown
Recruitment hospital [3] 0 0
St George Hospital - Kogarah
Recruitment hospital [4] 0 0
Liverpool Hospital - Liverpool
Recruitment hospital [5] 0 0
Prince Charles Hospital - Chermside
Recruitment hospital [6] 0 0
Princess Alexandra Hospital - Woolloongabba
Recruitment hospital [7] 0 0
The Queen Elizabeth Hospital - Woodville South
Recruitment hospital [8] 0 0
Monash Medical Centre - Clayton
Recruitment hospital [9] 0 0
Peter MacCallum Cancer Centre - Melbourne
Recruitment hospital [10] 0 0
St John of God Healthcare - Subiaco
Recruitment postcode(s) [1] 0 0
2148 - Blacktown
Recruitment postcode(s) [2] 0 0
2050 - Camperdown
Recruitment postcode(s) [3] 0 0
2217 - Kogarah
Recruitment postcode(s) [4] 0 0
2170 - Liverpool
Recruitment postcode(s) [5] 0 0
4032 - Chermside
Recruitment postcode(s) [6] 0 0
4102 - Woolloongabba
Recruitment postcode(s) [7] 0 0
5011 - Woodville South
Recruitment postcode(s) [8] 0 0
3168 - Clayton
Recruitment postcode(s) [9] 0 0
3000 - Melbourne
Recruitment postcode(s) [10] 0 0
6008 - Subiaco
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
California
Country [2] 0 0
United States of America
State/province [2] 0 0
Colorado
Country [3] 0 0
United States of America
State/province [3] 0 0
Connecticut
Country [4] 0 0
United States of America
State/province [4] 0 0
Delaware
Country [5] 0 0
United States of America
State/province [5] 0 0
District of Columbia
Country [6] 0 0
United States of America
State/province [6] 0 0
Florida
Country [7] 0 0
United States of America
State/province [7] 0 0
Georgia
Country [8] 0 0
United States of America
State/province [8] 0 0
Illinois
Country [9] 0 0
United States of America
State/province [9] 0 0
Indiana
Country [10] 0 0
United States of America
State/province [10] 0 0
Louisiana
Country [11] 0 0
United States of America
State/province [11] 0 0
Maryland
Country [12] 0 0
United States of America
State/province [12] 0 0
Massachusetts
Country [13] 0 0
United States of America
State/province [13] 0 0
Michigan
Country [14] 0 0
United States of America
State/province [14] 0 0
Minnesota
Country [15] 0 0
United States of America
State/province [15] 0 0
Missouri
Country [16] 0 0
United States of America
State/province [16] 0 0
Nevada
Country [17] 0 0
United States of America
State/province [17] 0 0
New Jersey
Country [18] 0 0
United States of America
State/province [18] 0 0
New York
Country [19] 0 0
United States of America
State/province [19] 0 0
North Carolina
Country [20] 0 0
United States of America
State/province [20] 0 0
Ohio
Country [21] 0 0
United States of America
State/province [21] 0 0
Oregon
Country [22] 0 0
United States of America
State/province [22] 0 0
South Carolina
Country [23] 0 0
United States of America
State/province [23] 0 0
Tennessee
Country [24] 0 0
United States of America
State/province [24] 0 0
Texas
Country [25] 0 0
United States of America
State/province [25] 0 0
Utah
Country [26] 0 0
United States of America
State/province [26] 0 0
Virginia
Country [27] 0 0
Belgium
State/province [27] 0 0
Brussels
Country [28] 0 0
Belgium
State/province [28] 0 0
Bruxelles
Country [29] 0 0
Belgium
State/province [29] 0 0
Charleroi
Country [30] 0 0
Belgium
State/province [30] 0 0
Edegem
Country [31] 0 0
Belgium
State/province [31] 0 0
Gent
Country [32] 0 0
Belgium
State/province [32] 0 0
Leuven
Country [33] 0 0
Belgium
State/province [33] 0 0
Liege
Country [34] 0 0
Belgium
State/province [34] 0 0
Roeselare
Country [35] 0 0
Belgium
State/province [35] 0 0
Sint-Niklaas
Country [36] 0 0
Brazil
State/province [36] 0 0
Rio Grande Do Sul
Country [37] 0 0
Brazil
State/province [37] 0 0
São Paulo
Country [38] 0 0
Brazil
State/province [38] 0 0
Rio de Janeiro
Country [39] 0 0
Canada
State/province [39] 0 0
Alberta
Country [40] 0 0
Canada
State/province [40] 0 0
Ontario
Country [41] 0 0
Canada
State/province [41] 0 0
Quebec
Country [42] 0 0
Denmark
State/province [42] 0 0
Herlev
Country [43] 0 0
Denmark
State/province [43] 0 0
København
Country [44] 0 0
Denmark
State/province [44] 0 0
Odense C
Country [45] 0 0
Finland
State/province [45] 0 0
Helsinki
Country [46] 0 0
Finland
State/province [46] 0 0
Oulu
Country [47] 0 0
Finland
State/province [47] 0 0
Turku
Country [48] 0 0
France
State/province [48] 0 0
Brest
Country [49] 0 0
France
State/province [49] 0 0
Créteil
Country [50] 0 0
France
State/province [50] 0 0
Grenoble
Country [51] 0 0
France
State/province [51] 0 0
Lille Cedex
Country [52] 0 0
France
State/province [52] 0 0
Limoges Cedex
Country [53] 0 0
France
State/province [53] 0 0
Lyon
Country [54] 0 0
France
State/province [54] 0 0
Marseille Cedex 20
Country [55] 0 0
France
State/province [55] 0 0
Paris Cedex 20
Country [56] 0 0
France
State/province [56] 0 0
Paris
Country [57] 0 0
France
State/province [57] 0 0
Pessac Cedex
Country [58] 0 0
France
State/province [58] 0 0
Pierre-Benite cedex
Country [59] 0 0
France
State/province [59] 0 0
Rennes
Country [60] 0 0
France
State/province [60] 0 0
Saint Herblain
Country [61] 0 0
France
State/province [61] 0 0
Strasbourg cedex
Country [62] 0 0
France
State/province [62] 0 0
Toulouse Cedex 9
Country [63] 0 0
France
State/province [63] 0 0
Villejuif
Country [64] 0 0
Germany
State/province [64] 0 0
Berlin
Country [65] 0 0
Germany
State/province [65] 0 0
Dresden
Country [66] 0 0
Germany
State/province [66] 0 0
Essen
Country [67] 0 0
Germany
State/province [67] 0 0
Esslingen am Neckar
Country [68] 0 0
Germany
State/province [68] 0 0
Frankfurt am Main
Country [69] 0 0
Germany
State/province [69] 0 0
Gauting
Country [70] 0 0
Germany
State/province [70] 0 0
Grosshansdorf
Country [71] 0 0
Germany
State/province [71] 0 0
Hamburg
Country [72] 0 0
Germany
State/province [72] 0 0
Heidelberg
Country [73] 0 0
Germany
State/province [73] 0 0
Immenstadt
Country [74] 0 0
Germany
State/province [74] 0 0
Köln
Country [75] 0 0
Germany
State/province [75] 0 0
Leipzig
Country [76] 0 0
Germany
State/province [76] 0 0
Moers
Country [77] 0 0
Germany
State/province [77] 0 0
Oldenburg
Country [78] 0 0
Greece
State/province [78] 0 0
Athens
Country [79] 0 0
Greece
State/province [79] 0 0
Heraklion - Crete
Country [80] 0 0
Greece
State/province [80] 0 0
Larissa
Country [81] 0 0
Greece
State/province [81] 0 0
Patra
Country [82] 0 0
Greece
State/province [82] 0 0
Thessaloniki
Country [83] 0 0
Hungary
State/province [83] 0 0
Budapest
Country [84] 0 0
Hungary
State/province [84] 0 0
Farkasgyepu
Country [85] 0 0
Hungary
State/province [85] 0 0
Gyula
Country [86] 0 0
Hungary
State/province [86] 0 0
Kaposvar
Country [87] 0 0
Hungary
State/province [87] 0 0
Miskolc
Country [88] 0 0
Hungary
State/province [88] 0 0
Szekesfehervar
Country [89] 0 0
Hungary
State/province [89] 0 0
Tatabanya
Country [90] 0 0
Hungary
State/province [90] 0 0
Torokbalint
Country [91] 0 0
Italy
State/province [91] 0 0
Avellino
Country [92] 0 0
Italy
State/province [92] 0 0
Bari
Country [93] 0 0
Italy
State/province [93] 0 0
Bologna
Country [94] 0 0
Italy
State/province [94] 0 0
Catania
Country [95] 0 0
Italy
State/province [95] 0 0
Firenze
Country [96] 0 0
Italy
State/province [96] 0 0
Milano
Country [97] 0 0
Italy
State/province [97] 0 0
Monserrato CA
Country [98] 0 0
Italy
State/province [98] 0 0
Monza (MB)
Country [99] 0 0
Italy
State/province [99] 0 0
Napoli
Country [100] 0 0
Italy
State/province [100] 0 0
Orbassano (TO)
Country [101] 0 0
Italy
State/province [101] 0 0
Padova
Country [102] 0 0
Italy
State/province [102] 0 0
Ravenna
Country [103] 0 0
Italy
State/province [103] 0 0
Roma
Country [104] 0 0
Japan
State/province [104] 0 0
Aichi
Country [105] 0 0
Japan
State/province [105] 0 0
Chiba
Country [106] 0 0
Japan
State/province [106] 0 0
Ehime
Country [107] 0 0
Japan
State/province [107] 0 0
Fukuoka
Country [108] 0 0
Japan
State/province [108] 0 0
Hiroshima
Country [109] 0 0
Japan
State/province [109] 0 0
Hokkaido
Country [110] 0 0
Japan
State/province [110] 0 0
Hyogo
Country [111] 0 0
Japan
State/province [111] 0 0
Ishikawa
Country [112] 0 0
Japan
State/province [112] 0 0
Kanagawa
Country [113] 0 0
Japan
State/province [113] 0 0
Kyoto
Country [114] 0 0
Japan
State/province [114] 0 0
Miyagi
Country [115] 0 0
Japan
State/province [115] 0 0
Niigata
Country [116] 0 0
Japan
State/province [116] 0 0
Okayama
Country [117] 0 0
Japan
State/province [117] 0 0
Osaka
Country [118] 0 0
Japan
State/province [118] 0 0
Saga
Country [119] 0 0
Japan
State/province [119] 0 0
Saitama
Country [120] 0 0
Japan
State/province [120] 0 0
Shiga
Country [121] 0 0
Japan
State/province [121] 0 0
Tokyo
Country [122] 0 0
Japan
State/province [122] 0 0
Tottori
Country [123] 0 0
Japan
State/province [123] 0 0
Wakayama
Country [124] 0 0
Japan
State/province [124] 0 0
Yamaguchi
Country [125] 0 0
Korea, Republic of
State/province [125] 0 0
Cheongju-si, Chungcheongbuk-do
Country [126] 0 0
Korea, Republic of
State/province [126] 0 0
Goyang-si Gyeonggi-do
Country [127] 0 0
Korea, Republic of
State/province [127] 0 0
Seongnam-si, Gyeonggi-do
Country [128] 0 0
Korea, Republic of
State/province [128] 0 0
Seoul
Country [129] 0 0
Korea, Republic of
State/province [129] 0 0
Ulsan
Country [130] 0 0
Netherlands
State/province [130] 0 0
Amsterdam
Country [131] 0 0
Netherlands
State/province [131] 0 0
Groningen
Country [132] 0 0
Netherlands
State/province [132] 0 0
Nijmegen
Country [133] 0 0
Netherlands
State/province [133] 0 0
Rotterdam
Country [134] 0 0
Netherlands
State/province [134] 0 0
Utrecht
Country [135] 0 0
Poland
State/province [135] 0 0
Gdansk
Country [136] 0 0
Poland
State/province [136] 0 0
Lublin
Country [137] 0 0
Poland
State/province [137] 0 0
Poznan
Country [138] 0 0
Poland
State/province [138] 0 0
Warszawa
Country [139] 0 0
Poland
State/province [139] 0 0
Wroclaw
Country [140] 0 0
Portugal
State/province [140] 0 0
Lisboa
Country [141] 0 0
Portugal
State/province [141] 0 0
Matosinhos
Country [142] 0 0
Portugal
State/province [142] 0 0
Porto
Country [143] 0 0
Russian Federation
State/province [143] 0 0
Moscow
Country [144] 0 0
Russian Federation
State/province [144] 0 0
Nizhniy Novgorod
Country [145] 0 0
Russian Federation
State/province [145] 0 0
Omsk
Country [146] 0 0
Russian Federation
State/province [146] 0 0
Saint-Petersburg
Country [147] 0 0
Spain
State/province [147] 0 0
AndalucÃ-a
Country [148] 0 0
Spain
State/province [148] 0 0
Canarias
Country [149] 0 0
Spain
State/province [149] 0 0
Cataluña
Country [150] 0 0
Spain
State/province [150] 0 0
Comunidad Valenciana
Country [151] 0 0
Spain
State/province [151] 0 0
Galicia
Country [152] 0 0
Spain
State/province [152] 0 0
Madrid
Country [153] 0 0
Sweden
State/province [153] 0 0
Gavle
Country [154] 0 0
Sweden
State/province [154] 0 0
Goteborg
Country [155] 0 0
Sweden
State/province [155] 0 0
Linkoping
Country [156] 0 0
Sweden
State/province [156] 0 0
Lund
Country [157] 0 0
Sweden
State/province [157] 0 0
Stockholm
Country [158] 0 0
Sweden
State/province [158] 0 0
Umea
Country [159] 0 0
Switzerland
State/province [159] 0 0
Basel
Country [160] 0 0
Switzerland
State/province [160] 0 0
Bern
Country [161] 0 0
Switzerland
State/province [161] 0 0
Geneve
Country [162] 0 0
Switzerland
State/province [162] 0 0
Lausanne
Country [163] 0 0
Switzerland
State/province [163] 0 0
Winterthur
Country [164] 0 0
Switzerland
State/province [164] 0 0
Zurich
Country [165] 0 0
Taiwan
State/province [165] 0 0
Taichung
Country [166] 0 0
Taiwan
State/province [166] 0 0
Tainan
Country [167] 0 0
Taiwan
State/province [167] 0 0
Taipei
Country [168] 0 0
United Kingdom
State/province [168] 0 0
Cambridge
Country [169] 0 0
United Kingdom
State/province [169] 0 0
Edinburgh
Country [170] 0 0
United Kingdom
State/province [170] 0 0
London
Country [171] 0 0
United Kingdom
State/province [171] 0 0
Manchester
Country [172] 0 0
United Kingdom
State/province [172] 0 0
Nottingham
Country [173] 0 0
United Kingdom
State/province [173] 0 0
Oxford
Country [174] 0 0
United Kingdom
State/province [174] 0 0
Sutton

Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Name
Amgen
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
A Phase 3 Study to Compare AMG 510 with Docetaxel in Non Small Cell Lung Cancer (NSCLC)
subjects with KRAS p. G12c mutation
Trial website
https://clinicaltrials.gov/ct2/show/NCT04303780
Trial related presentations / publications
de Langen AJ, Johnson ML, Mazieres J, Dingemans AC, Mountzios G, Pless M, Wolf J, Schuler M, Lena H, Skoulidis F, Yoneshima Y, Kim SW, Linardou H, Novello S, van der Wekken AJ, Chen Y, Peters S, Felip E, Solomon BJ, Ramalingam SS, Dooms C, Lindsay CR, Ferreira CG, Blais N, Obiozor CC, Wang Y, Mehta B, Varrieur T, Ngarmchamnanrith G, Stollenwerk B, Waterhouse D, Paz-Ares L; CodeBreaK 200 Investigators. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial. Lancet. 2023 Mar 4;401(10378):733-746. doi: 10.1016/S0140-6736(23)00221-0. Epub 2023 Feb 7.
Public notes

Contacts
Principal investigator
Name 0 0
MD
Address 0 0
Amgen
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT04303780